{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T18:20:03Z","timestamp":1789842003704,"version":"4.0.1"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.neuropharm.2022.109043","type":"journal-article","created":{"date-parts":[[2022,3,25]],"date-time":"2022-03-25T11:49:50Z","timestamp":1648208990000},"page":"109043","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["Reelin has antidepressant-like effects after repeated or singular peripheral injections"],"prefix":"10.1016","volume":"211","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9058-5561","authenticated-orcid":false,"given":"Josh","family":"Allen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel","family":"Romay-Tallon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milann A.","family":"Mitchell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4929-9042","authenticated-orcid":false,"given":"Kyle J.","family":"Brymer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2986-3179","authenticated-orcid":false,"given":"Jenessa","family":"Johnston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla L.","family":"S\u00e1nchez-Lafuente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graziano","family":"Pinna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa E.","family":"Kalynchuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hector J.","family":"Caruncho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2022.109043_bib1","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1503\/jpn.160175","article-title":"Antidepressant effects of ketamine and the roles of AMPA glutamate receptors and other mechanisms beyond NMDA receptor antagonism","volume":"42","author":"Aleksandrova","year":"2017","journal-title":"J. Psychiatry Neurosci."},{"key":"10.1016\/j.neuropharm.2022.109043_bib2","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1096\/fj.13-239350","article-title":"ApoER2 processing by presenilin-1 modulates reelin expression","volume":"28","author":"Balmacedo","year":"2014","journal-title":"FASEB"},{"key":"10.1016\/j.neuropharm.2022.109043_bib3","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2015.00037","article-title":"Sex hormones affect neurotransmitters and shape the adult female brain during hormonal transition periods","volume":"9","author":"Barth","year":"2015","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.neuropharm.2022.109043_bib4","doi-asserted-by":"crossref","first-page":"4281","DOI":"10.1093\/cercor\/bhw216","article-title":"Reelin regulates the maturation of dendritic spines, synaptogenesis and glial ensheathmenment of newborn granule cells","volume":"26","author":"Bosch","year":"2016","journal-title":"Cerebr. Cortex"},{"key":"10.1016\/j.neuropharm.2022.109043_bib5","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.yebeh.2015.04.046","article-title":"Aberrant hippocampal neurogenesis after limbic kindling: relationship to BDNF and hippocampal-dependent memory","volume":"47","author":"Botterill","year":"2015","journal-title":"Epilepsy Behav. : E&B"},{"key":"10.1016\/j.neuropharm.2022.109043_bib6","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.yhbeh.2012.02.024","article-title":"Stress-induced sex differences: adaptations mediated by the glucocorticoid receptor","volume":"62","author":"Bourke","year":"2012","journal-title":"Horm. Behav."},{"key":"10.1016\/j.neuropharm.2022.109043_bib7","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0014-2999(01)01148-7","article-title":"Paradoxical effects of chronic corticosterone on forced swim behaviours in aged male and female rats","volume":"424","author":"Brotto","year":"2001","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2022.109043_bib8","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3389\/fphar.2018.00121","article-title":"Peripheral etanercept administration normalizes behavior, hippocampal neurogenesis, and hippocampal reelin and GABAA receptor expression in a preclinical model of depression","volume":"9","author":"Brymer","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.neuropharm.2022.109043_bib9","doi-asserted-by":"crossref","first-page":"98","DOI":"10.3389\/fnins.2019.00098","article-title":"Exploring the potential antidepressant mechanisms of TNFalpha antagonists","volume":"13","author":"Brymer","year":"2019","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.neuropharm.2022.109043_bib10","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1038\/s41386-020-0609-z","article-title":"Fast-acting antidepressant-like effects of Reelin evaluated in the repeated-corticosterone chronic stress paradigm","volume":"45","author":"Brymer","year":"2020","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2022.109043_bib11","first-page":"25","article-title":"GABA, Reelin, and the neurodevelopmental hypothesis of schizophrenia","volume":"16","author":"Caruncho","year":"2004","journal-title":"Crit. Rev. Neurobiol."},{"key":"10.1016\/j.neuropharm.2022.109043_bib12","doi-asserted-by":"crossref","first-page":"48","DOI":"10.3389\/fncel.2016.00048","article-title":"Reelin-related disturbances in depression: implications for translational studies","volume":"10","author":"Caruncho","year":"2016","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.neuropharm.2022.109043_bib13","doi-asserted-by":"crossref","first-page":"190","DOI":"10.3389\/fphar.2019.00190","article-title":"Patterns of membrane protein clustering in peripheral lymphocytes as predictors of therapeutic outcomes in major depressive disorder","volume":"10","author":"Caruncho","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.neuropharm.2022.109043_bib14","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1021\/acschemneuro.7b00042","article-title":"The rodent forced swim test measures stress-coping strategy, not depression-like behavior","volume":"8","author":"Commons","year":"2017","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.neuropharm.2022.109043_bib15","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/sj.mp.4000783","article-title":"Reduction in Reelin immunoreactivity in hippocampus of subjects with schizophrenia, bipolar disorder and major depression","volume":"5","author":"Fatemi","year":"2000","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2022.109043_bib16","doi-asserted-by":"crossref","first-page":"3209","DOI":"10.1097\/00001756-200110290-00014","article-title":"Altered levels of Reelin and its isoforms in schizophrenia and mood disorders","volume":"12","author":"Fatemi","year":"2001","journal-title":"Neuroreport"},{"key":"10.1016\/j.neuropharm.2022.109043_bib17","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.pnpbp.2015.02.001","article-title":"Imipramine protects against the deleterious effects of chronic corticosterone on depression-like behavior, hippocampal reelin expression, and neuronal maturation","volume":"60","author":"Fenton","year":"2015","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"4","key":"10.1016\/j.neuropharm.2022.109043_bib18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0215554","article-title":"Stress-sensitive antidepressant-like effects of ketamine in the mouse forced swim test","volume":"14","author":"Fitzgerald","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2022.109043_bib19","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.bbr.2004.05.013","article-title":"Effect of repeated corticosterone injections and restraint stress on anxiety and depression-like behavior in male rats","volume":"156","author":"Gregus","year":"2005","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2022.109043_bib20","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1001\/archpsyc.57.11.1061","article-title":"Decrease in reelin and glutamic acid decarboxylase67 (GAD67) expression in schizophrenia and bipolar disorder: a postmortem brain study","volume":"57","author":"Guidotti","year":"2000","journal-title":"Arch. Gen. Psychiatr."},{"key":"10.1016\/j.neuropharm.2022.109043_bib21","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.nlm.2009.10.006","article-title":"Effects of acute stress and GluN2B-containing NMDA receptor antagonism on object and object-place recognition memory","volume":"93","author":"Howland","year":"2010","journal-title":"Neurobiol. Learn. Mem."},{"key":"10.1016\/j.neuropharm.2022.109043_bib22","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.neuroscience.2011.11.011","article-title":"Altered object-in-place recognition memory, prepulse inhibition, and locomotor activity in the offspring of rats exposed to a viral mimetic during pregnancy","volume":"201","author":"Howland","year":"2012","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2022.109043_bib23","doi-asserted-by":"crossref","first-page":"15718","DOI":"10.1073\/pnas.95.26.15718","article-title":"A decrease of reelin expression as a putative vulnerability factor in schizophrenia","volume":"95","author":"Impagnatiello","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.neuropharm.2022.109043_bib24","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.bbr.2005.11.019","article-title":"Effect of different doses of corticosterone on depression-like behavior and HPA axis responses to a novel stressor","volume":"168","author":"Johnson","year":"2006","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2022.109043_bib25","doi-asserted-by":"crossref","first-page":"559627","DOI":"10.3389\/fphar.2020.559627","article-title":"Ketamine rescues hippocampal reelin expression and synaptic markers in the repeated-corticosterone chronic stress paradigm","volume":"11","author":"Johnston","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.neuropharm.2022.109043_bib26","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1037\/0735-7044.118.6.1365","article-title":"Corticosterone increases depression-like behavior, with some effects on predator odor-induced defensive behavior, in male and female rats","volume":"118","author":"Kalynchuk","year":"2004","journal-title":"Behav. Neurosci."},{"key":"10.1016\/j.neuropharm.2022.109043_bib27","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/dvdy.24462","article-title":"Nonneuronal roles for the reelin signaling pathway","volume":"246","author":"Khialeeva","year":"2017","journal-title":"Dev. Dynam."},{"key":"10.1016\/j.neuropharm.2022.109043_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJMp1903305","article-title":"Esketamine for treatment-resistant depression - first FDA-approved antidepressant in a new class","volume":"381","author":"Kim","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.neuropharm.2022.109043_bib29","article-title":"A key requirement for synaptic Reelin signaling in ketamine-mediated behavioral and synaptic action","volume":"118","author":"Kim","year":"2021","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.neuropharm.2022.109043_bib30","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/j.0953-8194.2004.01167.x","article-title":"Androgen inhibits, while oestrogen enhances, restraint-induced activation of neuropeptide neurones in the paraventricular nucleus of the hypothalamus","volume":"16","author":"Lund","year":"2004","journal-title":"J. Neuroendocrinol."},{"key":"10.1016\/j.neuropharm.2022.109043_bib31","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.neulet.2009.05.050","article-title":"Repeated exposure to corticosterone, but not restraint, decreases the number of reelin-positive cells in the adult rat hippocampus","volume":"460","author":"Lussier","year":"2009","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2022.109043_bib32","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/j.neuropharm.2010.09.007","article-title":"Reelin as a putative vulnerability factor for depression: examining the depressogenic effects of repeated corticosterone in heterozygous reeler mice","volume":"60","author":"Lussier","year":"2011","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2022.109043_bib33","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.neuropharm.2013.04.012","article-title":"The progressive development of depression-like behavior in corticosterone-treated rats is paralleled by slowed granule cell maturation and decreased reelin expression in the adult dentate gyrus","volume":"71","author":"Lussier","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2022.109043_bib34","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.neuroscience.2012.11.037","article-title":"Altered GABAergic and glutamatergic activity within the rat hippocampus and amygdala in rats subjected to repeated corticosterone administration but not restraint stress","volume":"231","author":"Lussier","year":"2013","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2022.109043_bib35","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.physbeh.2009.04.014","article-title":"Repeated exposure to corticosterone increases depression-like behavior in two different versions of the forced swim test without altering nonspecific locomotor activity or muscle strength","volume":"98","author":"Marks","year":"2009","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.neuropharm.2022.109043_bib36","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s12868-015-0156-4","article-title":"Reelin expression in brain endothelial cells: an electron microscopy study","volume":"16","author":"Perez-Costas","year":"2015","journal-title":"BMC Neurosci"},{"key":"10.1016\/j.neuropharm.2022.109043_bib37","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/1471-2202-7-77","article-title":"Variability of doublecortin-associated dendrite maturation in adult hippocampal neurogenesis is independent of the regulation of precursor cell proliferation","volume":"7","author":"Plumpe","year":"2006","journal-title":"BMC Neurosci."},{"key":"10.1016\/j.neuropharm.2022.109043_bib38","doi-asserted-by":"crossref","first-page":"4636","DOI":"10.1523\/JNEUROSCI.5284-09.2010","article-title":"Reelin regulates postnatal neurogenesis and enhances spine hypertrophy and long-term potentiation","volume":"30","author":"Pujadas","year":"2010","journal-title":"J. Neurosci. Off. J. Soc. Neurosci."},{"key":"10.1016\/j.neuropharm.2022.109043_bib39","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0014-2999(03)01272-X","article-title":"The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review","volume":"463","author":"Purt","year":"2003","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2022.109043_bib40","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/S0022-2275(20)31625-4","article-title":"Localization of apolipoprotein E receptor 2 to caveolae in the plasma membrane","volume":"42","author":"Riddell","year":"2001","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.neuropharm.2022.109043_bib41","article-title":"Serotonin transporter clustering in blood lymphocytes of reeler mice","volume":"7","author":"Rivera-Baltanas","year":"2010","journal-title":"Cardiovasc. Psychiatry Neurol."},{"key":"10.1016\/j.neuropharm.2022.109043_bib42","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jad.2011.12.041","article-title":"Serotonin transporter clustering in blood lymphocytes as a putative biomarker of therapeutic efficacy in major depressive disorder","volume":"137","author":"Rivera-Baltanas","year":"2012","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.neuropharm.2022.109043_bib43","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jad.2014.03.011","article-title":"Serotonin 2A receptor clustering in peripheral lymphocytes is altered in major depression and may be a biomarker of therapeutic efficacy","volume":"163","author":"Rivera-Baltanas","year":"2014","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.neuropharm.2022.109043_bib44","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s12991-015-0085-8","article-title":"Serotonin transporter clustering in blood lymphocytes predicts the outcome on anhedonia scores in na\u00efve depressive patients treated with antidepressant medication","volume":"14","author":"Rivera-Baltanas","year":"2015","journal-title":"Ann. Gen. Psychiatr."},{"key":"10.1016\/j.neuropharm.2022.109043_bib45","doi-asserted-by":"crossref","DOI":"10.1186\/s40364-017-0107-6","article-title":"Comparative study of two protocols for quantitative image-analysis of serotonin transporter clustering in lymphocytes, a putative biomarker of therapeutic efficacy in major depression","volume":"5","author":"Romay-Tallon","year":"2017","journal-title":"Biomark Res."},{"key":"10.1016\/j.neuropharm.2022.109043_bib46","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.3389\/fphar.2018.01149","article-title":"Changes in membrane protein clustering in peripheral lymphocytes in an animal model of depression parallel those observed in na\u00efve depression patients: implications for the development of novel biomarkers of depression","volume":"9","author":"Romay-Tallon","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.neuropharm.2022.109043_bib47","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1080\/1363849031000095279","article-title":"Estrogen and progesterone as neuroprotective agents in the treatment of acute brain injuries","volume":"6","author":"Stein","year":"2003","journal-title":"Pediatr. Rehabil."},{"key":"10.1016\/j.neuropharm.2022.109043_bib48","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.pnpbp.2010.03.005","article-title":"Behavioral and neurobiological consequences of prolonged glucocorticoid exposure in rats: relevance to depression","volume":"34","author":"Sterner","year":"2010","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2022.109043_bib49","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/s00018-009-0201-5","article-title":"Reelin is a platelet protein and functions as a positive regulator of platelet spreading on fibrinogen","volume":"67","author":"Tseng","year":"2010","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.neuropharm.2022.109043_bib50","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1111\/jth.12736","article-title":"Impaired thrombin generation in Reelin-deficient mice: a potential role of plasma Reelin in hemostasis","volume":"12","author":"Tseng","year":"2014","journal-title":"J. Thromb. Haemostasis"}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390822001022?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390822001022?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T07:17:50Z","timestamp":1758439070000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390822001022"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":50,"alternative-id":["S0028390822001022"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2022.109043","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reelin has antidepressant-like effects after repeated or singular peripheral injections","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2022.109043","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109043"}}